Detalhe da pesquisa
1.
Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Eur J Cancer
; 127: 12-20, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31962198
2.
⢠Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.
Eur Surg
; 50(4): 160-166, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559831
3.
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
J Thorac Cardiovasc Surg
; 148(5): 2280-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135238
4.
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
J Thorac Cardiovasc Surg
; 135(5): 1036-41, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18455581
5.
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.
Ann Surg
; 235(4): 493-8, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11923604